Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...

A team of Australian researchers has developed a new targeted therapeutic approach that could improve treatment for myelofibrosis -- a rare form of blood cancer ...

Chemotherapy usually works well at reducing the size of the spleen. But rarely, some people need an operation to remove their spleen (splenectomy). The spleen's normal job is to filter the blood and ...